Literature DB >> 12417425

Galactolipids are molecular determinants of myelin development and axo-glial organization.

Jill Marcus1, Brian Popko.   

Abstract

Myelination is a developmentally regulated process whereby myelinating glial cells elaborate large quantities of a specialized plasma membrane that ensheaths axons. The myelin sheath contains an unusual lipid composition in that the glycolipid galactosylceramide (GalC) and its sulfated form sulfatide constitute a large proportion of the total lipid mass. These glycolipids have been implicated in a range of developmental processes such as cell differentiation and myelination initiation, but analyses of mice lacking UDP-galactose:ceramide galactosyltransferase (CGT), the enzyme required for myelin galactolipid synthesis, have more recently demonstrated that the galactolipids more subtly regulate myelin formation. The CGT mutants display a delay in myelin maturation and axo-glial interactions develop abnormally. By interbreeding the CGT mutants with mice that lack myelin-associated glycoprotein, it has been shown that these specialized myelin lipids and proteins act in concert to promote axo-glial adhesion during myelinogenesis. The analysis of the CGT mutants is helping to clarify the roles myelin galactolipids play in regulating the development, and ultimately the function of the myelin sheath.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12417425     DOI: 10.1016/s0304-4165(02)00410-5

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  34 in total

Review 1.  Multi-dimensional mass spectrometry-based shotgun lipidomics and the altered lipids at the mild cognitive impairment stage of Alzheimer's disease.

Authors:  Xianlin Han
Journal:  Biochim Biophys Acta       Date:  2010-02-01

2.  Assessment of cortical maturation with prenatal MRI. Part I: Normal cortical maturation.

Authors:  Céline Fogliarini; Katia Chaumoitre; Frédérique Chapon; Carla Fernandez; Olivier Lévrier; Dominique Figarella-Branger; Nadine Girard
Journal:  Eur Radiol       Date:  2005-04-23       Impact factor: 5.315

3.  Age-related molecular reorganization at the node of Ranvier.

Authors:  Jason D Hinman; Alan Peters; Howard Cabral; Douglas L Rosene; William Hollander; Matthew N Rasband; Carmela R Abraham
Journal:  J Comp Neurol       Date:  2006-04-01       Impact factor: 3.215

Review 4.  Directing traffic in neural cells: determinants of receptor tyrosine kinase localization and cellular responses.

Authors:  Robert J Romanelli; Teresa L Wood
Journal:  J Neurochem       Date:  2008-06-01       Impact factor: 5.372

Review 5.  Biosynthesis and immunogenicity of glucosylceramide in Cryptococcus neoformans and other human pathogens.

Authors:  Ryan Rhome; Travis McQuiston; Talar Kechichian; Alicja Bielawska; Mirko Hennig; Monica Drago; Giulia Morace; Chiara Luberto; Maurizio Del Poeta
Journal:  Eukaryot Cell       Date:  2007-08-10

Review 6.  It's a lipid's world: bioactive lipid metabolism and signaling in neural stem cell differentiation.

Authors:  Erhard Bieberich
Journal:  Neurochem Res       Date:  2012-01-14       Impact factor: 3.996

Review 7.  The pathogenic implication of abnormal interaction between apolipoprotein E isoforms, amyloid-beta peptides, and sulfatides in Alzheimer's disease.

Authors:  Xianlin Han
Journal:  Mol Neurobiol       Date:  2010-01-07       Impact factor: 5.590

8.  Ceramide galactosyltransferase (UGT8) is a molecular marker of breast cancer malignancy and lung metastases.

Authors:  P Dzięgiel; T Owczarek; E Plazuk; A Gomułkiewicz; M Majchrzak; M Podhorska-Okołów; K Driouch; R Lidereau; M Ugorski
Journal:  Br J Cancer       Date:  2010-07-20       Impact factor: 7.640

9.  In vivo antioxidative and neuroprotective effect of 4-Allyl-2-methoxyphenol against chlorpyrifos-induced neurotoxicity in rat brain.

Authors:  Varsha Singh; Rupali Panwar
Journal:  Mol Cell Biochem       Date:  2013-12-01       Impact factor: 3.396

Review 10.  Lipid rafts in neurodegeneration and neuroprotection.

Authors:  Sandro Sonnino; Massimo Aureli; Sara Grassi; Laura Mauri; Simona Prioni; Alessandro Prinetti
Journal:  Mol Neurobiol       Date:  2013-12-22       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.